5-MeO-DMT

Psychedelics R&D biotech Biomind Labs Inc. (OTC: BMNDF) has completed the development of a novel sublingual formulation and the first production batch for testing in its Phase 2 trial on proprietary 5-MeO-DMT-based drug candidate, BMND08, for the treatment of depression and anxiety states in...

Private clinical-stage psychedelics biotech Beckley Psytech Ltd. has initiated a Phase 2a proof-of-concept study on BPL-003, its proprietary intranasal formulation of synthetic 5-MeO-DMT for Treatment-Resistant Depression (TRD.) Founded in 2019 and yet based on more than two decades of...

Public psychedelics practitioner training program F.I.V.E. is set to collaborate with Tandava Retreats and University College London (UCL) on what will be the first-ever EEG brain imaging study of 5-MeO-DMT done in retreat center participants. While the psychoactive compound traditionally...

Private clinical-stage psychedelics biotech Beckley Psytech announced it has successfully completed a Phase 1 clinical study on BPL-003, its patent-protected, synthetic intranasal formulation of 5-MeO-DMT under development for Treatment-Resistant Depression (TRD) and Alcohol Use Disorder (AUD.)...

Biotech company focused on creating next-gen serotonergic neuroplastogen psychedelic compounds to treat severe neuropsychiatric and neurological conditions Lusaris Therapeutics launched with a $60 million Series A financing.  The round was led by the company’s incubator, RA Capital...

Researchers at the University of Texas (UT) Dell Medical School in Austin will use brain scans to examine responses following treatment with psilocybin and 5-MeO-DMT for combatants suffering from post-traumatic stress disorder (PTSD), traumatic brain injuries and other related conditions. The...

Life and sciences R&D company Biomind Labs Inc. (OTC: BMNDF) received a Controlled Substances License to begin an eight-month exclusive collaboration with Queen’s University of Belfast to produce and evaluate rapidly-dissolving and sustained-release hydrogel-forming microneedle...

Biomind Labs Inc. (OTC: BMNDF), a life sciences company developing medicinal next-generation psychedelics, completed the dose administration of 30 healthy subjects within its Phase 2 clinical trial of DMT-based proprietary drug BMND01 for the Treatment-Resistant Depression (TDR) disorder. Besides...

PsyBio Therapeutics (TSXV: PSYB) (OTCQB: PSYBF), a biotech developing medicines based on naturally-occurring psychedelic substances, and mushroom producer Red Light Holland Corp. (OTC Pink: TRUFF) announced the release of financial results and operational highlights. The First Six Months...

GH Research PLC (NASDAQ: GHRS), the clinical-stage biopharma company dedicated to transforming the treatment of psychiatric and neurological disorders through 5-MeO-DMT production, provided a financial and business update for the quarter ended June 30, 2022. The financial results for the...

This article was originally published on Psychedelic Spotlight and appears here with permission. The psychedelic facilitators tell us open-minded participants, who have a willingness to dive deep into their inner world generally have the most success at the Tandava Retreat wellness center in...

You can add the Sonoran Desert Toad to the current escalating body count of threatened species worldwide, as the amphibious creature’s psychoactive secretions continue to gain popularity with psychedelic enthusiasts. Increased interest in Bufo alvarius toad venom — derived...

This article was originally published on The Bluntness and appears here with permission. New discoveries about what psychedelics do inside the human brain to help treat depression, PTSD, addiction, dementia and even phantom limb pain are coming fast and furious as...

Beckley Psytech, a private company in the psychedelics space, announced that it has begun training psychotherapists for a Phase 2 clinical trial with 5-MeO-DMT, a strong and fast-acting psychedelic compound naturally produced by the Sonoran Desert Toad. The company launched a program to study 5-MeO...

This article was originally published on Microdose and appears here with permission. A brief history of DMT N,N-Dimethyltryptamine, known as DMT or the “spirit molecule”, is a compound found throughout nature that has profound effects on human consciousness. The importance of...